Author

Gary L. Norman

Director Research and Development, Inova Diagnostics - Cited by 7,023 - autoimmunity - hepatology - gastroenterology - serology - celiac

Biography

Dr.Gary L. Norman belong to INOVA Diagnostics, Inc., San Diego, CA, USA He is a  Director Research and Development, Inova Diagnostics  he is expertise of cLiver Diseases Antibodies ELISA Autoimmunity Flow Cytometry Inflammation Cell Culture Hepatocellular Carcinoma Innate Immunity Immunology of Infectious Diseases
Title
Cited by
Year
Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome
CB Chighizola, F Pregnolato, L Andreoli, C Bodio, L Cesana, C Comerio, ...Journal of autoimmunity 90, 76-83, 2018201
60
2018
“Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort
T Liu, J Gu, L Wan, Q Hu, J Teng, H Liu, X Cheng, J Ye, Y Su, Y Sun, ...Arthritis research & therapy 22 (1), 1-11, 2020202
58
2020
Gluten-free diet reduces symptoms, particularly diarrhea, in patients with irritable bowel syndrome and antigliadin IgG
MI Pinto-Sanchez, A Nardelli, R Borojevic, G De Palma, NC Calo, ...Clinical Gastroenterology and Hepatology 19 (11), 2343-2352. e8, 2021202
33
2021
Serum autotaxin is a useful disease progression marker in patients with primary biliary cholangitis
S Joshita, T Umemura, Y Usami, Y Yamashita, GL Norman, A Sugiura, ...Scientific Reports 8 (1), 8159, 2018201
29
2018
Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
NK Gatselis, T Tornai, Z Shums, K Zachou, A Saitis, S Gabeta, R Albesa, ...World Journal of Gastroenterology 26 (34), 5130, 2020202
28
2020
Anti–Domain I β2-Glycoprotein I Antibodies and Activated Protein C Resistance Predict Thrombosis in Antiphospholipid Syndrome: TAC(I)T Study
S Zuily, B de Laat, F Guillemin, H Kelchtermans, N Magy-Bertrand, ...The journal of applied laboratory medicine 5 (6), 1242-12, 2020202
25
2020
The prevalence of anti-hexokinase-1 and anti-kelch-like 12 peptide antibodies in patients with primary biliary cholangitis is similar in Europe and North America: a large …
GL Norman, A Reig, O Viñas, M Mahler, E Wunsch, P Milkiewicz, ...Frontiers in immunology 10, 662, 2019201
24
2019
Anti-β2GPI domain 1 antibodies stratify high risk of thrombosis and late pregnancy morbidity in a large cohort of Chinese patients with antiphospholipid syndrome
T Liu, J Gu, L Wan, Q Hu, J Teng, H Liu, X Cheng, J Ye, Y Su, Y Sun, ...Thrombosis research 185, 142-149, 2020202
21
2020
Novel anti–hexokinase 1 antibodies are associated with poor prognosis in patients with primary biliary cholangitis
A Reig, GL Norman, M Garcia, Z Shums, S Ruiz-Gaspà, C Bentow, ...Official journal of the American College of Gastroenterology| ACG 115 (10 …,
20
2020
Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome
S Zhang, Z Wu, W Zhang, J Zhao, GL Norman, X Zeng, F Zhang, Y LiClinical Chemistry and Laboratory Medicine (CCLM) 56 (6), 939-946, 2018201
17
2018
Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and …
E Wunsch, GL Norman, M Milkiewicz, M Krawczyk, C Bentow, Z Shums, ...Alimentary Pharmacology & Therapeutics 53 (2), 302-313, 2021202
17
2021
The IgA isotype of anti-β2 glycoprotein I antibodies recognizes epitopes in domains 3, 4, and 5 that are located in a lateral zone of the molecule (L-Shaped)
M Serrano, JA Martinez-Flores, GL Norman, L Naranjo, JM Morales, ...Frontiers in immunology 10, 1031, 2019201
16
2019
KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
T Umemura, S Joshita, H Saito, K Yoshizawa, GL Norman, E Tanaka, ...JHEP Reports 1 (5), 353-360, 2019201
16
2019
Comparison of celiac disease markers in women with early recurrent pregnancy loss and normal controls
MA Kutteh, M Abiad, GL Norman, WH KuttehAmerican Journal of Reproductive Immunology 82 (1), e137, 2019201
12
2019
Comprehensive review of autoantibodies in patients with hyper-IgM syndrome
MR Barbouche, Q Chen, M Carbone, I Ben-Mustapha, Z Shums, M Trifa, ...Cellular & Molecular Immunology 15 (6), 610-617, 2018201
11
2018
Serum cartilage oligomeric matrix protein and Golgi protein-73: new diagnostic and predictive tools for liver fibrosis and hepatocellular cancer?
NK Gatselis, K Zachou, G Giannoulis, S Gabeta, GL Norman, GN DalekosCancers 13 (14), 3510, 2021202
11
2021
Anti‐C1q autoantibodies are frequently detected in patients with systemic sclerosis associated with pulmonary fibrosis
C Liaskos, S Rentouli, T Simopoulou, A Gkoutzourelas, GL Norman, ...British Journal of Dermatology 181 (1), 138-146, 2019201
11
2019
Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis
D Villalta, A Seaman, M Tiongson, C Warren, C Bentow, N Bizzaro, ...Clinical Chemistry and Laboratory Medicine (CCLM) 58 (9), 1499-1507, 2020202
10
2020
Autoantibodies in patients with interleukin 12 receptor beta 1 deficiency
V Ronca, QB Chen, V Lygoura, I Ben‐Mustapha, Z Shums, M Trifa, ...Journal of Digestive Diseases 20 (7), 363-370, 20120
9
2019
Anti-phosphatidylserine/prothrombin antibodies at two points: correlation with lupus anticoagulant and thrombotic risk
N Egri, C Bentow, L Rubio, GL Norman, S López-Sañudo, M Mahler, ...Frontiers in immunology, 4334, 2021202
9
2021

Referred From: https://scholar.google.com/citations?user=ChPvElcAAAAJ&hl=en

Cited by
Citations 7023
h-index 49
i10-index 111
Recommended Journals
Open Access Journals